Understanding and exploiting mechanisms of structural change in the brain will lead to improved treatments for diseases such as Alzheimers and schizophrenia. The Conway neuroscience research programme consists of 13 research groups, 10 of which are housed in the Institute. Research interests in the group are diverse with particular strengths in neurodegeneration, neurotherapeutics and neuroinflammation.
Cognitive function and psychiatric illness
novel therapies for Alzheimers, depression and autism
memory-associated synaptic plasticity
zebrafish models of cone photoreceptor disease
neurotransmitter function and toxicity
biomarkers for neurodegenerative and psychiatric illnesses.
Neurodevelopment, neurodegenerative disease and neuroinflammation
prion protein (PrP) biology, transmission and association with Alzheimers disease
synaptic transmission and plasticity
composition and regulation of the serotonin transporter complex (SERT)
Caenorhabditis elegans as model for cilia-related diseases
molecular genetics amyotrophic lateral sclerosis